person

Rocco P.

Country
Italy
Department
UOC Oncologia Medica

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
32
Sites with multiple studies

Has run more than one trial at 32 of 136 partner sites.

Specializations

Bladder Cancer Research

The investigator specializes in treating non-muscle invasive bladder cancer (NMIBC), with particular focus on cases involving FGFR gene alterations. Their research extends to innovative intravesical treatment approaches for patients with bladder cancer.

  • High-risk NMIBC management
  • FGFR-positive intermediate-risk cases
  • Intravesical therapy development

The investigator explores treatment options for patients who have received Bacillus Calmette-Guérin (BCG) therapy and experienced recurrence.

Prostate Cancer Research

The investigator focuses on advanced therapeutic strategies for high-risk localized and locally advanced prostate cancer. Their research encompasses combination treatments using androgen deprivation therapy (ADT) with novel therapeutic agents.

  • Combined hormone therapy approaches
  • Pre- and post-surgical treatment protocols
  • Advanced imaging applications

Their work includes evaluation of treatment outcomes using PSMA PET imaging and conventional imaging methods.

Therapeutic Innovation

The investigator develops and evaluates novel therapeutic approaches for urological cancers, with emphasis on intravesical drug delivery systems and targeted therapies.

  • Alternative treatment strategies for surgery-ineligible patients
  • Disease-free survival optimization
  • Personalized treatment protocols

Their research includes assessment of treatment outcomes in patients who are not candidates for radical cystectomy.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.